
Home prices favour buyers in some Canadian markets, sellers in others: RBC
Local real estate board statistics show transactions increased modestly between May and June in several major markets, including Vancouver, Edmonton, Regina, Saskatoon, Toronto and Halifax. However, the gains only represent a fraction of pullbacks earlier this year.
'When you look at various metrics, you know buyers now have much more of a stronger hand when negotiating prices,' said Robert Hogue, assistant chief economist for RBC.
The MLS Home Price Index (HPI) fell in Toronto, Vancouver, southern Ontario and lower mainland markets. These are markets in the country where inventory has risen to historically high levels, and buyers face stretched affordability conditions.
'Markets in southern Ontario, as well as B.C., are soft., however it looks like, over the last couple of months, the slide in activity, appears to be now stabilizing, so things don't look like they're getting any softer from an activity perspective,' said Hogue.
'But prices continue to fall in those markets. That's likely because of a stretch of affordability that's holding back a lot of buyers that can't really get up prices in the current context, and the fact that those markets are really heavily in favour of buyers. At this point, there's a lot of competition between sellers and less between buyers, so those markets are seeing price declines.'
Meanwhile, property values continue to be higher in most markets in the Prairies, Quebec and the Atlantic region, supported by still tight (and, in some cases, very tight) supply-demand conditions.
'Other parts of the country, the situation is different,' said Hogue. 'We've seen some correction during the spring in the face of the trade war, that really affected confidence across the board. But the level of activity in most cases, I'm thinking in particular in the prairies, either in Saskatchewan or in Alberta, to a fair extent, not everywhere, but to a fair extent, the level of activity is still pretty robust. When you compare it to pre-pandemic levels, sort of same situation in markets like Montreal, for example. Now we've seen a bit of a slowdown lately, but nonetheless, the level is still, I would argue, compares pretty well relative to pre-pandemic level.'
Buyers in Toronto have time and bargaining power
The Toronto area is experiencing an abundance of homebuying options not seen in decades as the number of homes for sale continues to surge. The trend favours buyers giving them more time to make decisions and power in negotiating prices.
Toronto's MLS HPI in June was down 5.5 per cent (or more than $58,000) year over yearand lower by 0.9 per cent from May. Condo apartments recorded the biggest decline at eight per cent due to plentiful supply, but all housing types lost some value.
Despite slightly improving affordability and easing trade war fears attracting more buyers to the market in June, home resales picked up 8.1 per cent from May, marking a third consecutive monthly increase. However, Hogue said recovery has a long way to go. Activity remains sluggish near cyclical lows amid growing job concerns.
Sellers hold back in stalled Montreal market
Montreal's recovery has stalled this year in the face of the trade war, according to RBC. The bank estimates resales slipped for a third straight month between May and June, falling approximately two per cent.
However, resales are holding up at what would have been considered solid levels before the pandemic.
The bank says June's modest pullback may have more to do with fewer sellers entering the market than buyers shying away. New listings fell by seven per cent from May to June,which has tightened the demand dynamic further.
This has maintained price pressure on both single-family homes and condos sustaining solid appreciation last month with median prices up 7.4 per cent and 6.6 per cent from a year ago.
Prices firmly on a downtrend in Vancouver
The slide in resales in Vancouver is stabilizing though prices remain firmly on a down track.
Vancouver's MLS HPI declined 2.8 per cent from a year ago, marking the fourth straight month of annual declines.
Buyers are in the driver's seat with supply-demand conditions heavily favouring them amid mounting inventories. Active listings reached a 13-year high in June, yet home resales rose for the first time this year, up more than two percent in May.
Calgary experiences a soft landing
Calgary continues to cool as inventory rises and prices soften. The city's MLS HPI fell in May and June, down 3.6 per cent in the latest period, though the bank sees limited downside for property values given aligned supply and demand conditions.
Calgary is a market where supply and demand are largely aligned, and affordability is only mildly strained. The city is also supported by a relatively robust economy.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CTV News
29 minutes ago
- CTV News
Stellantis' financial losses less concerning for ‘stable' Windsor Assembly Plant, analyst says
Windsor Assembly Plant seen in Windsor, Ont. on April 3, 2025. (Chris Campbell/CTV News Windsor) A large financial blow to Stellantis is not expected to cause major changes at the Windsor Assembly Plant, according to an automotive analyst. On Monday, the auto giant reported preliminary estimates showing a 2.3 billion Euros (US$2.68 billion) net loss through the first half of 2025. 'It won't help them that's for sure, and Stellantis is already in a decent spot of trouble,' said David Kennedy, the Toronto Bureau Chief for Automotive News Canada. At the heart of the automaker's losses are U.S. tariffs and other charges. It's estimated tariffs will create an added cost of about 300 million euros tacked on to its bottom line. Compared to the Brampton Assembly Plant, where Stellantis has hit pause on $1.3 billion retooling plans, Kennedy noted production is more 'stable' in Windsor. 'We've seen announcements of a couple-week shutdowns at a time since tariffs were announced, but Windsor is a little bit more insulated, simply based on the fact that they're already up and running, they're not retooling,' Kennedy explained. Kennedy added the company still has plans in Windsor for 'reliable' minivan production as well as the Daytona. 'Basically, the Windsor plant is on firmer footing than Brampton,' Kennedy said. In a statement to CTV News, Lana Payne, Unifor's national president, said the financial findings add to 'mounting uncertainty' for the auto sector. 'For Unifor members in Canada, particularly at the Brampton and Windsor Assembly Plants, today's news only adds to mounting uncertainty,' Payne said. 'This is partly the company's own doing but also reflective of the damaged economic conditions for automakers that's entirely Donald Trump's fault.' Payne went on to add that any level of permanent tariffs will 'devastate' the auto industry. Stellantis is set to release its final results for the first half of the year on July 29.


Globe and Mail
29 minutes ago
- Globe and Mail
Sharp Therapeutics Corp. Announces Results from Annual Meeting of Shareholders
Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - Sharp Therapeutics Corp. (TSXV: SHRX) (" Sharp" or the " Company"), a pre-clinical biotechnology company developing small molecule therapies to treat genetic diseases, is pleased to announce the voting results from its annual general meeting of shareholders held on July 18, 2024 (the " Meeting"). All nominees set forth in the Company's management information circular dated June 10, 2025 (the " Circular") were elected as directors of the Company at the Meeting. Detailed results of the votes are set out below: The Circular also sought approval to re-appoint MNP LLP as auditors of the Company and to authorize the board of directors of the Company to fix the auditors' remuneration. The results of the shareholder votes for this item is set out below: Motion Number of Shares For Percentage of Votes For Appointment of Auditors 10,923,102 100 % About Sharp Therapeutics Corp. First-Choice Therapies for Genetic Diseases Sharp Therapeutics is a pre-clinical stage company developing first-choice small-molecule therapeutics for genetic diseases. The Company's discovery platform combines novel high throughput screening technologies, with compound libraries computational optimized based on the physics and biology of cellular trafficking defects and allosteric activation of proteins. The platform produces small molecule compounds that restore activity in mutated proteins giving the potential to treat genetic disorders with conventional pill-based medicines. For additional information on Sharp, please visit: To view the source version of this press release, please visit


CTV News
29 minutes ago
- CTV News
Alcohol to be sold at LaSalle Vipers games
If you are an avid LaSalle Vipers fan, you may soon see alcohol available for sale at the games. Town administration said it will recommend approving alcohol sales during the hockey games at the Vollmer Complex. The plan will see the G.O.A.T Tap and Eatery selling the drinks. Service would begin 45 minutes before every game, wrapping up when there are 10 minutes left in the third period. The restaurant would provide a licensed security guard and bartender, while two volunteers with the Vipers would monitor consumption in the food court. 'The town's got some pretty strict alcohol policies,' said Councillor Jeff Renaud with the Town of LaSalle. 'That's why you only see a very limited number of licensed events happening throughout the town. They've worked with administration to fit within our policies and make it affordable for them to run the business as well. It looks to me by the report, it's a pretty well-thought-out proposal.'